Revenue growth went from 111% in q1 v pcp, to 84%, or in USD from 122% to 97% for a start. Ebitda margin fell about one-third, from 33.5% to 24.5%, which is a huge fall. Looking forward to Jan a growth rate of 66%, or 82% CC.
Significant deceleration is not priced in.
